Feb 08, 2022 / 08:00PM GMT
Operator
Good day, and welcome to the Second Annual Winter Wonderland Best Ideas Conference. The next presenting company is Medexus Pharmaceuticals. (Operator Instructions) I'd now like to turn the floor over to today's host, Ken d'Entremont, CEO of Medexus Pharmaceuticals. Sir, the floor is yours.
Kenneth d'Entremont - Medexus Pharmaceuticals Inc. - CEO & Director
Thank you very much, and thank you to the organizers of the Winter Wonderland Conference for the opportunity to present Medexus here today. Our forward-looking statements are available on our website at medexus.com.
So just starting with an overview of the company, Medexus is really a focused commercial pharmaceutical company working in the orphan drug rare disease space in both the U.S. and Canada. We've got a fully built-out organization commercially in both territories, generating revenue of around USD 80 million off of about 16 products in total in the 2 countries, producing strong growth over the few years that we've been together. And about 12% ownership by management and
Medexus Pharmaceuticals Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers